幸运飞艇输死你

血液病研究所CAR-T臨床研究獲Best of ASH殊榮
發布時間:2019-12-13
訪問次數:636
分享到:

    DI61JIEMEIGUOXUEYEBINGXUEHUINIANHUI(ASH)YUOrlandoDANGDISHIJIAN2019NIAN12YUE7RI-10RIZHAOKAI。GAIHUIYISHISHIJIEXUEYEBINGLINGYUGUIMOHEYINGXIANGLIZUIDADEXUESHUSHENGHUI,HUIJULELAIZIQUANQIULIUDAZHOUDE30000YUMINGXUEYEBINGLINGYULINCHUANGHESHIYANKEXUEJIA,GONGTONGTANTAOXUEYEBINGXUEDEXINJISHU、XINFAXIANHEXINJINZHAN。HUISHANG,WOYUANXUEYEBINGYANJIUSUOCAR-TLINCHUANGYANJIUHUOBest of ASHSHURONG。

幸运飞艇输死你     WOYUANXUEYEBINGYANJIUSUOSUOCHANGHUYUJIAOSHOUHEMEIHENGJIAOSHOUXIBAOZHILIAOTUANDUISHOUYAOFABIAODAHUIYANJIANG。ZHEYESHIJIDI24JIEOUZHOUXUEYEXUEDAHUIBAOGAOHOUZAICIYINQIGUOJITONGXINGGAODUHAOPING。CIWAI,MEINIANASH pressXIANGMUHUANHUIPINGXUANDANGNIANZUIJUYINGXIANGLIDEYANJIUCHENGGUOJINXINGZHUANTITAOLUNBINGZHAOKAIXINWENFABUHUI。JINNIANHUYUJIAOSHOUTONGMEIGUOBINXIFANIYADAXUEDECAR-TDANIUStephen J. SchusterJIAOSHOUDENG4WEIYANJIUZHESHOUYAOCHUXILETIWEI“ASH CAR-T and Beyond Press Briefing: Rapid Therapeutic Advances for Treatment of Blood Cancers”DEXINWENFABUHUI,BAOGAOLEBCMA+CD38SHUANGBADIANCAR-TZHILIAONANZHI/FUFADUOFAXINGGUSUILIU1QIJILIANGDIZENGSHIYANDEGENGXINJIEGUO,HUIDALE30YUJIAGUOJIMEITIJIXUESHUQIKANDEJIZHEYONGYUETIWEN。ZHESHIGUONEICAR-TXIBAOZHILIAOYANJIUTUANDUISHOUCISHOUYAOJUXINGASHXINWENFABUHUI,TIXIANCHUGUOJITONGXINGDEGAODURENKE。

幸运飞艇输死你     ZAIHUIYIBIMUSHIZUIJIAYANJIUPINGXUANHUANJIE(Best of ASH),HUYUJIAOSHOUHEMEIHENGJIAOSHOUDEYANJIUCHENGGUOCONG10000YUPIANHUIYILUNWENJI1000YUXIANGDAHUIBAOGAOZHONGTUOYINGERCHU,CHENGGONGRUXUANBest of ASH,YOUSHIJIEZHUMINGXUEYEXUEJIACharles G. MullighanJIAOSHOUZAIDAHUIBIMUSHISHANGJINXINGLEZHUANMENZHANSHI。GAIXIANGCHENGGUODAIBIAOLEXUEYELINGYUDEZUIZHONGYAOTUPOHEWEILAIFAZHANFANGXIANG,ZHEYESHIZHONGGUOYISHENGDELINCHUANGYANJIUSHOUCIHUODEBest of ASHSHURONG。

    DAHUIQIJIAN,DUOJIAGUOJIZHIMINGXUESHUMEITIDUIHUYUJIAOSHOUTUANDUIDEYANJIUCHENGGUOJINXINGLESHENRUBAODAO。

    JUXI,CAR-TZHILIAOTUANDUIZUOWEIXIEHEYIYUANXUEYANSUOZUINIANQINGDEYAZHUANKE,2015NIANLVXIANTONGGUOHUBEISHENGWEISHENGTING、KEJITINGLIANHESHENPI,CHENGLIYICAR-TZHILIAOWEITESEDEHUBEISHENGZHONGLIUJIBINGXIBAOZHILIAOLINCHUANGYIXUEYANJIUZHONGXIN。ZAICAR-TZHILIAOKEJIBUZHONGDIANYANFAZHUANXIANGSHOUXIKEXUEJIAHUYUJIAOSHOUDEDAILINGXIA,GAIZHONGXINMUQIANYIKAIFACD19、BCMA、CD38、CD30、CD22、CD123DENGXILIEBATOU,YONGYOUXIBAOZHILIAOBINGFANGHEGMPSHIYANSHISHESHI;JIEZHI2019NIAN12YUE,YIWANCHENG150LINANZHIFUFAXUEYEZHONGLIUHUANZHE(BAIXUEBING、LINBALIU、GUSUILIU)DECAR-TXIBAOZHILIAO,ZONGTIHUANJIELVGAODA88.2%,ZUICHANG1LIWUBINGSHENGCUNSHIJIANYICHANGDA48GEYUE,DAIBIAODANGQIANGUOJIXIANJINSHUIPING;YANJIUCHENGGUOZAIMEIGUOXUEYEXUENIANHUI、OUZHOUXUEYEXUENIANHUI、ZHONGHUAXUEYEXUEHUI、ZHONGGUOXUEYEBINGYISHIXIEHUI、ZHONGGUOXIBAOZHILIAODAHUIDENGGEJIDAHUIBAOGAOHUOZHUANTIJIANGZUO20YURENCI,LUNWENFABIAOZAIClin Cancer Res、Am J Haematol、 Br J Haematol DENGGUOJIGAOSHUIPINGXUESHUKANWU。MUQIANHUANZHELAIYUANYIFUSHEHUBEI、HENAN、FUJIAN、JIANGXI、XINJIANG、HUNAN、GUANGXI、HAINAN、HEILONGJIANG、SHANXI、BEIJING、SHANGHAI、LIAONING、NEIMENGGU、ANHUIDENG15SHENGSHIJIXINJIAPODENGHAIWAIGUOJIAHEDIQU。

    WOYUANXUEYANSUOJIANGYICANYUCICIDAHUIHUODEDEGUOJIYINGXIANGWEIQIJI,JINYIBUTIGAOGUOJIHUASHUIPINGHENENGLI,JIXUJIZHONGYOUSHIKEYANLILIANG,GONGKEXUEYEZHONGLIUNANGUAN,RANGGENGDUOHUANZHEHEJIASHUZAORIZOUCHUJIBINGYINYING。(XIEHEYIYUANXUEYANSUO)

    

    相關外媒報道:

     http://www.medscape.com/viewarticle/922298

     http://www.healio.com/hematology-oncology/myeloma/news/online/%7B85eca842-f742-4200-9a95-9239fcb63c0c%7D/bispecific-car-t-cell-therapy-safe-effective-for-advanced-multiple-myeloma

     http://ascopost.com/news/december-2019/dose-climbing-trial-of-dual-target-car-t-cell-therapy-for-relapsed-or-refractory-multiple-myeloma/

     http://www.hematology.org/Newsroom/Press-Releases/2019/10096.aspx

     

相關閱讀:
友情鏈接
微信服務號二維碼
微信訂閱號二維碼
Copyrights ? 2002-2015 All Rights Reserved. 醫院地址:湖北省武漢市解放大道1277號 郵編:430022 鄂ICP備 05004666  
醫院總機:027-85726114